Microbiome therapeutics for the treatment of recurrent <i>Clostridioides difficile</i> infection
Patricia P. Bloom, Vincent B. Young
Abstract
INTRODUCTION: infection (CDI) and recurrent CDI (rCDI). AREAS COVERED: This review covers the mechanisms by which microbiome therapeutics treat rCDI, their efficacy and safety, and clinical trial design considerations for future research. EXPERT OPINION: .
Topics & Concepts
ClostridioidesMicrobiomeMedicineClostridium difficileDysbiosisIntensive care medicineBiologyImmunologyMicrobiologyComputational biologyBioinformaticsAntibioticsInternal medicineClostridium difficile and Clostridium perfringens researchGastrointestinal motility and disordersGut microbiota and health